Xlife Sciences invests in Fuse-AI
The Swiss company Xlife Sciences invests in the AI start-up Fuse-AI. Fuse-AI develops the ProstateCarcinoma.ai assistance system for the diagnosis of prostate cancer based on annotated MRI data using AI technology.
The companies did not provide any details regarding the financial details of the agreement and the amount of the investment.